Clinical Utility of a Precision Medicine Test Evaluating Outpatients with Suspected Obstructive Coronary Artery DiseaseJoseph A. Ladapo, Mark Monane, Bruce Maniet et al.|The American Journal of Medicine|2016Cited by 15
Utility of a Precision Medicine Test in Elderly Adults with Symptoms Suggestive of Coronary Artery DiseaseJoseph A. Ladapo, Mark Monane, Lee Herman et al.|Journal of the American Geriatrics Society|2017Cited by 5
The Clinical Utility of a Precision Medicine Blood Test Incorporating Age, Sex, and Gene Expression for Evaluating Women with Stable Symptoms Suggestive of Obstructive Coronary Artery Disease: Analysis from the PRESET RegistryBurcu Gül, Joseph A. Ladapo, Alexandra J. Lansky et al.|Journal of Women s Health|2019Cited by 2
Use of a Blood-Based Age/Sex/Gene Expression Test Was Associated with Prescriptions for Lipid-Lowering Medications and Lifestyle Changes among Symptomatic Patients at Increased Cardiovascular Risk for Obstructive Coronary Artery Disease: Subgroup AnalysisGregory S. Pokrywka, Linda Ross, Matthew J. Budoff et al.|Journal of clinical lipidology|2015Cited by 1
Abstract 142: Primary Endpoint Results from a Community-Based Registry Evaluating the Use of a Blood-Based Age/Sex/Gene Expression Test in Patients Presenting with Symptoms Suggestive of Obstructive Coronary Artery Disease: the PRESET Registry (A Registry to Evaluate Patterns of Care Associated with the Use of Corus® CAD in Real World Clinical Care Settings)Joseph A. Ladapo, Richard F. Wright, Matthew J. Budoff et al.|Circulation Cardiovascular Quality and Outcomes|2015Cited by 1